Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

UniCredit, CNP seek extension of call option on insurance JV, sources say

Stock Markets Dec 01, 2021 15:23
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A UniCredit logo is seen in downtown Rome, May 10, 2016. REUTERS/Tony Gentile
 
AV
-1.84%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CRDI
+0.98%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CNPP
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AVVIY
-5.96%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
VENM
-1.37%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CNPAY
+0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Valentina Za

MILAN (Reuters) -UniCredit is looking to extend a deadline for a call option that would allow Italy's second-biggest bank to take full ownership of an insurance joint venture with France's CNP Assurances, two sources close to the matter said.

Both UniCredit and CNP declined to comment.

CNP Assurances on Tuesday completed the acquisition of British rival Aviva (LON:AV)'s life insurance business in Italy.

As part of a push to focus on its core markets, Aviva in March agreed to sell to CNP a 51% stake in Aviva SpA, a life insurance joint venture with UniCredit, which is being renamed CNP Vita Assicura.

CNP said on Tuesday the accord with UniCredit over CNP Vita Assicura gives the bank the right to buy CNP's 51% stake at a set premium to the price the French insurer paid to Aviva.

The call option expires on Dec. 30, 2021, it said.

The two sources speaking on condition of anonymity said the parties were discussing extending the deadline to allow UniCredit to decide over the medium-term whether to take over in full the life insurance joint-venture.

They did not specify when a new deadline would be, but the aim would be to take advantage of an anticipated more favourable regulatory treatment of banks' stakes in insurers and help to boost UniCredit's fee income.

UniCredit, which is presenting a new strategy on Dec. 9 under new Chief Executive Andrea Orcel, is looking to streamline its domestic insurance operations, likely retaining only two partners, two other people close to the matter said. The partnership with Aviva formerly and now CNP is one of five joint ventures through which UniCredit runs its domestic insurance business. Its other partners are Germany's Allianz (DE:ALVG) and Bologna-based UnipolSai. CNP had another life joint-venture in place with UniCredit before the deal with Aviva. Under the Aviva deal, CNP has also acquired 100% of Aviva Life and 93% of Aviva Italia Servizi, which provides business support services.

If UniCredit exercises the call option, CNP Assurances has the right to also sell Aviva Life and Aviva Italia Servizi to UniCredit at the price it paid Aviva, CNP said.

UniCredit, CNP seek extension of call option on insurance JV, sources say
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email